These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 27860070)
1. CHA Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070 [TBL] [Abstract][Full Text] [Related]
2. Association of CHA Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240 [TBL] [Abstract][Full Text] [Related]
3. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1. Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724 [TBL] [Abstract][Full Text] [Related]
4. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III. Baker WL; Coleman CI; White CM; Kluger J Pharmacotherapy; 2013 May; 33(5):489-95. PubMed ID: 23649811 [TBL] [Abstract][Full Text] [Related]
5. CHA Su CH; Tsao TF; Chen AC; Chang KW; Yang YS; Ueng KC; Tsai CF Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29288496 [TBL] [Abstract][Full Text] [Related]
6. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores. Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M; Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032 [TBL] [Abstract][Full Text] [Related]
7. CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta-analysis. Vitali F; Serenelli M; Airaksinen J; Pavasini R; Tomaszuk-Kazberuk A; Mlodawska E; Jaakkola S; Balla C; Falsetti L; Tarquinio N; Ferrari R; Squeri A; Campo G; Bertini M Clin Cardiol; 2019 Mar; 42(3):358-364. PubMed ID: 30597581 [TBL] [Abstract][Full Text] [Related]
8. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre. Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506 [TBL] [Abstract][Full Text] [Related]
9. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation. Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434 [TBL] [Abstract][Full Text] [Related]
10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
11. The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke. Cha MJ; Lee HS; Kim YD; Nam HS; Heo JH Eur J Neurol; 2013 Sep; 20(9):1256-63. PubMed ID: 23560528 [TBL] [Abstract][Full Text] [Related]
12. Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA Zuo K; Sun L; Yang X; Lyu X; Li K Clin Cardiol; 2017 Feb; 40(2):120-125. PubMed ID: 28075503 [TBL] [Abstract][Full Text] [Related]
13. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services. Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863 [TBL] [Abstract][Full Text] [Related]
14. CHA2 DS2 VASc Score as a Predictor of Cardiovascular Events in Ambulatory Patients without Atrial Fibrillation. Polenz GF; Leiria TL; Essebag V; Kruse ML; Pires LM; Nogueira TB; Guimarães RB; Santanna RT; DE Lima GG Pacing Clin Electrophysiol; 2015 Dec; 38(12):1412-7. PubMed ID: 26310935 [TBL] [Abstract][Full Text] [Related]
15. Baseline CHA Díez-Villanueva P; Vera A; Ariza-Solé A; Formiga F; Martínez-Sellés M; Alegre O; Sanchís J; Marín F; Vidán M; López-Palop R; Abu-Assi E; Bueno H; Alfonso F; Int J Clin Pract; 2021 Jun; 75(6):e14082. PubMed ID: 33565683 [TBL] [Abstract][Full Text] [Related]
16. A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation. Lip GY; Potpara T; Boriani G; Blomström-Lundqvist C J Intern Med; 2016 May; 279(5):467-76. PubMed ID: 27001354 [TBL] [Abstract][Full Text] [Related]
17. Risk of ischemic stroke and utility of CHA Tomasdottir M; Friberg L; Hijazi Z; Lindbäck J; Oldgren J Clin Cardiol; 2019 Oct; 42(10):1003-1009. PubMed ID: 31490011 [TBL] [Abstract][Full Text] [Related]
18. Value of the CHA Shuvy M; Zwas DR; Keren A; Gotsman I ESC Heart Fail; 2020 Oct; 7(5):2553-2560. PubMed ID: 32614479 [TBL] [Abstract][Full Text] [Related]
19. Augmented intelligence decision tool for stroke prediction combines factors from CHA Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of renal dysfunction in patients with acute coronary syndrome-role beyond the CHA2 DS2 -VASc score: Data from Taiwan acute coronary syndrome full spectrum registry. Chua SK; Lo HM; Chiu CZ; Shyu KG; Nephrology (Carlton); 2016 Jul; 21(7):583-91. PubMed ID: 26469710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]